San Diego "Top Doctor" James Veltmeyer Collaborates with Therapeutic Solutions International in Cord Blood Based Immunotherapy
May 12 2020 - 9:00AM
InvestorsHub NewsWire
San Diego "Top Doctor" James Veltmeyer Collaborates with
Therapeutic Solutions International in Cord Blood Based
Immunotherapy for COVID-19 Damaged Lungs
New
Findings in Biology of Coronavirus Leads to New Data and the
Possibility of Reducing Ventilator Associated Mortality
OCEANSIDE, CA -- May
12, 2020 -- InvestorsHub NewsWire -- Therapeutics
Solutions International, Inc., (OTC
Markets:
TSOI) announced the
filing of
a new
patent
application with lead inventor
Dr. James Veltmeyer, Chief Medical Officer of TSOI and previously
chosen as Top Doctor of San Diego in
2012,
2014, 2016, 2017,
and
2019.
The patent
application covers new data in which combinations of pterostilbene
and other compounds with cord blood are shown to be
capable
of suppressing lung inflammation associated with COVID19 in an
animal model. The data is an extension of previous work by
the Company in which patents have been
filed and
issued for immune modulation and reduction of inflammatory cytokine
activation called "cytokine storm".
"The problem with the
current situation is that everything has become about politics and
not enough about patients,"
said
Dr. James Veltmeyer. "As someone who is working on the frontlines,
I am comforted by the
work in
our company, and others, in
developing
natural and regenerative means of combatting this virus….not just
throwing toxic chemicals with the hope that some will kill the
virus slightly more than they kill healthy cells."
Dr. Veltmeyer
was a Congressional
Candidate in 2018 and is active in the fight to bring awareness and
change to the current Healthcare Crisis.
"It is refreshing to
synergize
our basic
laboratory skills and expertise with clinical input and wisdom that
Dr. Veltmeyer gives us. The motto of our company is to
utilize these synergies to accelerate the development of potential
treatments such as this one, and our previously announced,
QuadraMune, in order to give
patients a fighting chance"
said Tim
Dixon, President, and CEO of TSOI.
About
Therapeutic Solutions International, Inc.
Therapeutic Solutions
International is focused on immune modulation for the treatment of
several specific diseases. Immune modulation refers to the ability
to upregulate (make more active) or downregulate (make less active)
one's immune system. The Company's corporate website is at
www.therapeuticsolutionsint.com
and our
e-commerce is at www.youcanordernow.com and for additional
info on QuadraMune™
visit www.areyoucovidmune.com/covidmune/.
These statements have
not been evaluated by the Food and Drug Administration. These
products are not intended to diagnose, treat, cure, or prevent any
disease.
Therapeutic Solutions
International, Inc.
ir@tsoimail.com
- New Patent Filing on Cord Blood Based
Immunotherapy for COVID-19 Damaged Lungs
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Sep 2023 to Sep 2024